The Potential of Angiogenin as a Serum Biomarker for Diseases: Systematic Review and Meta-Analysis

Abstract EN

Background.

Angiogenin (ANG) is a multifunctional angiogenic protein that participates in both normal development and diseases.

Abnormal serum ANG levels are commonly reported in various diseases.

However, whether ANG can serve as a diagnostic or prognostic marker for different diseases remains a matter of debate.

Methods.

Here, we performed a systematic review and meta-analysis of the literature utilizing PubMed, Web of Science, and Scopus search engines to identify all publications comparing plasma or serum ANG levels between patients with different diseases and healthy controls, as were studies evaluating circulating ANG levels in healthy populations, pregnant women, or other demographic populations.

Results.

This study demonstrated that the serum ANG concentration in healthy populations was 336.14 ± 142.83 ng/ml and remained relatively stable in different populations and regions.

We noted no significant differences in serum ANG levels between patients and healthy controls, except in cases in which patients suffered from cancer or cardiovascular diseases.

The serum ANG concentrations were significantly higher in patients who developed colorectal cancer, acute myeloid leukemia, multiple myeloma, myelodysplastic syndromes, and heart failure than those in healthy controls.

Conclusion.

ANG has the potential of being a serum biomarker for cancers and cardiovascular diseases.